Template: Difference between revisions

From Top Italian Scientists Journal
No edit summary
No edit summary
Line 1: Line 1:
*Open Access | Review | Biomedical Sciences
*Open Access | Review | Biomedical Sciences
: Massimo Milani and Francesca Colombo, [[The_rational_of_a_fixed_combination_of_benzoyl_peroxide_and_niacinamide_in_the_treatment_of_acne_vulgaris_A_narrative_review#Benzoyl_Peroxide_and_Niacinamide%3A_Drugs_Characteristics | The rational of a fixed combination of benzoyl peroxide and niacinamide in the treatment of acne vulgaris: A narrative review]], ''Top Italian Scientists Journal'' 1(1), 18 January 2024
: Massimo Milani and Francesca Colombo, [[The_rational_of_a_fixed_combination_of_benzoyl_peroxide_and_niacinamide_in_the_treatment_of_acne_vulgaris_A_narrative_review | The rational of a fixed combination of benzoyl peroxide and niacinamide in the treatment of acne vulgaris: A narrative review]], ''Top Italian Scientists Journal'' 1(1), 18 January 2024





Revision as of 17:58, 18 January 2024

  • Open Access | Review | Biomedical Sciences
Massimo Milani and Francesca Colombo, The rational of a fixed combination of benzoyl peroxide and niacinamide in the treatment of acne vulgaris: A narrative review, Top Italian Scientists Journal 1(1), 18 January 2024


Published
January 14, 2024
Title
Rationale and design of a prospective, open-label, randomized, multicentric clinical trial on the role of drug-coated balloons for bifurcation coronary lesions: the PRO-DAVID study
Authors
Đeiti Prvulović, MD(a) Bernardo Cortese, MD(b,c)
Keywords
DCB; coronary bifurcations; study design
Downloads
Download PDF
Download PDF

Đeiti Prvulović, MD(a) Bernardo Cortese, MD(b,c)

(a)Clinical Hospital Center Rijeka, Rijeka, Croatia

(b)Fondazione Ricerca e Innovazione Cardiovascolare, Milano, Italy

(c)DCB Academy, Milano, Italy

Fundings: none.

Disclosures: none.

Address for correspondence: Bernardo Cortese, MD, FESC, Cardiovascular Research Group, Fondazione Ricerca e Innovazione Cardiovascolare, Milano, Italy. Via E. Ponti 49, Milano, Italy. bcortese@gmail.com - Running head: DCB use for coronary bifurcations.

Declaration of interest: none.